Inventor · disambiguated record
James R. Woods
Also filed as: WOODS JAMES · WOODS JAMES R
6 granted patents·5 pending applications·17 citations·filing 2002–2024
76Inventor score
Top patents by PatentIndex Score
11 records- 0191US12006330B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2021·Granted Jun 11, 2024·2 cites·113 claims
- 0290US12054495B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2022·Granted Aug 6, 2024·1 cites·51 claims
- 0388US11760747B2Substituted piperidino compounds and related methods of treatmentALKERMES INC·Filed 2021·Granted Sep 19, 2023·1 cites·121 claims
- 0484US11542276B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2020·Granted Jan 3, 2023·1 cites·122 claims
- 0579US2025092063A1Substituted Macrocyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 0678US12441710B2Substituted piperidino compounds and related methods of treatmentALKERMES INC·Filed 2023·Granted Oct 14, 2025·0 cites·47 claims
- 0776US7205314B2Compounds for the treatment of dementia related diseasesASTRAZENECA AB·Filed 2002·Granted Apr 17, 2007·12 cites·8 claims
- 0874US2024368182A1Substituted Macrocyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 0964US2024174689A1Substituted carbamate macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2023·Application pending·0 cites
- 1064US2024182491A1Substituted fused bicyclic macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2023·Application pending·0 cites
- 1163US2024124485A1Substituted amide macrocyclic compounds with orexin-2 receptor agonist activityALKERMES INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James R. Woods files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →